Certain Other Dosage Form New Animal Drugs; Sevoflurane

摘要

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Abbott Laboratories. The NADA provides for use of sevoflurane as an inhalant for induction and maintenance of general anesthesia in dogs.